Pharmaceuticals market research reports by GlobalData

• Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review ... Read More

• Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review ... Read More

• Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic SWOT Analysis Review ... Read More

• Emergent BioSolutions Inc (EBS) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Emergent BioSolutions Inc (EBS) - Financial and Strategic SWOT Analysis Review ... Read More

• GSK plc (GSK) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  GSK plc (GSK) - Financial and Strategic SWOT Analysis Review ... Read More

• Novavax Inc (NVAX) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Novavax Inc (NVAX) - Financial and Strategic SWOT Analysis Review ... Read More

• Parexel International Corp - Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Parexel International Corp - Strategic SWOT Analysis Review ... Read More

• Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review ... Read More

• Dongsung Pharm Co Ltd (002210) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Dongsung Pharm Co Ltd (002210) - Financial and Strategic SWOT Analysis Review ... Read More

• Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review ... Read More

• Benitec Biopharma Inc (BNTC) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Benitec Biopharma Inc (BNTC) - Financial and Strategic SWOT Analysis Review ... Read More

• Ionis Pharmaceuticals Inc (IONS) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Ionis Pharmaceuticals Inc (IONS) - Financial and Strategic SWOT Analysis Review ... Read More

• Kolon Life Science Inc (102940) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Kolon Life Science Inc (102940) - Financial and Strategic SWOT Analysis Review ... Read More

• AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review ... Read More

• Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review ... Read More

• Sanofi (SAN) - Financial and Strategic SWOT Analysis Review

  Nov 13, 2024  |  Published by: GlobalData  |  USD 125

  Sanofi (SAN) - Financial and Strategic SWOT Analysis Review ... Read More

• Orthopedic Bone Cement and Casting Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  Nov 08, 2024  |  Published by: GlobalData  |  USD 4,000

  Orthopedic Bone Cement and Casting Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Orthopedic Bone Cement and Casting Materials Pipeline Report including Sta ... Read More

• Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  Nov 08, 2024  |  Published by: GlobalData  |  USD 2,500

  Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segmen ... Read More

• Opportunities in the Global OTC Healthcare Sector 2024

  Nov 08, 2024  |  Published by: GlobalData  |  USD 3,450

  Opportunities in the Global OTC Healthcare Sector 2024 Summary The global OTC healthcare sector was valued at $175.2 billion in 2023 and is expected to yield a CAGR of 2.6% during 2023-28, to reach $199.4 billion in 2028. The Americas was the largest market in the global OTC healthcare sector in 202 ... Read More

• Strategic Intelligence: AI in drug discovery

  Nov 06, 2024  |  Published by: GlobalData  |  USD 1,950

  Strategic Intelligence: AI in drug discovery Summary In recent years, the pharma industry has been taken over by a wave of digital transformation, leading to the integration of advanced technologies across different aspects of the pharma value chain. Artificial intelligence (AI) and big data are at ... Read More

• Glomerulonephritis: Competitive Landscape

  Nov 05, 2024  |  Published by: GlobalData  |  USD 3,495

  Glomerulonephritis: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Glomerulonephritis therapeutics. GlobalData epidemiologists estimate that there will be 51,900 diagnosed incident cases of ANCA-associated GMN in 2024, wh ... Read More

• Strategic Intelligence: Pharma M&A Deals Q3 2024 - Top Themes

  Nov 01, 2024  |  Published by: GlobalData  |  USD 495

  Strategic Intelligence: Pharma M&A Deals Q3 2024 - Top Themes Summary This report analyzes the disruptive themes that have driven M&A activity in Q3 2024 in the pharma Sector. The global pharma sector in Q3 2024 witnessed deals worth $35 billion, a decline of 3% compared to Q3 2023. In terms of deal ... Read More

• Strategic Intelligence: Big Data in Pharma

  Oct 31, 2024  |  Published by: GlobalData  |  USD 1,950

  Strategic Intelligence: Big Data in Pharma Summary Big data is generated extensively across pharma The international pharmaceutical landscape generates vast amounts of data from a variety of sources, such as patient registries, clinical trials, wearable technologies, and more. Such datasets are extr ... Read More

• Fidson Healthcare Plc (FIDSON) - Financial and Strategic SWOT Analysis Review

  Oct 30, 2024  |  Published by: GlobalData  |  USD 125

  Fidson Healthcare Plc (FIDSON) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea ... Read More

• Pharmesis International Ltd (BFK) - Financial and Strategic SWOT Analysis Review

  Oct 30, 2024  |  Published by: GlobalData  |  USD 125

  Pharmesis International Ltd (BFK) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More

< prev 4 5 6 7 8 9 10 11 12 13 next >